Morningstar Analyst: Abbott Laboratories' Acquisition Of St. Jude Medical 'Makes A Lot Of Strategic Sense'

By: via Benzinga
Debbie Wang, an analyst at Morningstar explained during an interview on Bloomberg TV why Abbott Laboratories (NYSE: ABT) acquisition of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.